Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was up 26.7% during trading on Friday . The stock traded as high as $3.90 and last traded at $3.75. 119,807 shares traded hands during mid-day trading, an increase of 83% from the average session volume of 65,333 shares. The stock had previously closed at $2.96.
Alpha Tau Medical Stock Performance
The business’s 50-day moving average is $2.55 and its two-hundred day moving average is $1.50.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
See Also
- Five stocks we like better than Alpha Tau Medical
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
